CIK: 0001825034 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $172,084 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV PHARMACEUTICALS INC | 2,336,909 | $48,654 | 28.3% | $39.23 | -55.0% | COM | 69353Y103 |
| — | 23ANDME HOLDING CO | 10,243,122 | $39,231 | 22.8% | $3.83 | — | CLASS A COM | 90138Q108 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,261,261 | $19,209 | 11.2% | $19.16 | -28.4% | COM | 344174107 |
| ALEC | ALECTOR INC | 980,894 | $13,978 | 8.1% | $12.43 | +27.3% | COM | 014442107 |
| — | NGM BIOPHARMACEUTICALS INC | 746,674 | $11,387 | 6.6% | $30.30 | — | COM | 62921N105 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $10,787 | 6.3% | $21.49 | -43.7% | COM | 87990A106 |
| — | RAPT THERAPEUTICS INC | 432,900 | $9,519 | 5.5% | $19.75 | — | COM | 75382E109 |
| COIN | COINBASE GLOBAL INC | 46,922 | $8,909 | 5.2% | $195.40 | 0.0% | COM CL A | 19260Q107 |
| FFBC | FIRST FINL BANCORP OH | 173,576 | $4,001 | 2.3% | $12.77 | +66.7% | COM | 320209109 |
| ORIC | ORIC PHARMACEUTICALS INC | 747,550 | $3,992 | 2.3% | $28.69 | -68.6% | COM | 68622P109 |
| — | SURROZEN INC | 802,963 | $2,417 | 1.4% | $7.08 | — | COM | 86889P109 |